Throat lozenges could be contributing to antimicrobial resistance

  13 April 2019

The inappropriate use of OTC sore throat medications that contain antibiotics could thus be preventing hindering the WHO’s plans to tackle AMR in order to “ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines.

Further reading: PharmaFile
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed